MUC1 and colonic neoplasm: As MUC1 is expressed on early premalignant lesions as well as cancer, we chose to study immunogenicity, safety and potential efficacy of this vaccine in the preventative setting in individuals with a history of colonic polyps that increases their risk of colon cancer (13).